M&T Bank Corp Eli Lilly & CO Transaction History

M&T Bank Corp

$28.6 Billion
Q1 2024

A detailed history of M&T Bank Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, M&T Bank Corp holds 229,507 shares of LLY stock, worth $208 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

229,507

Previous 205,838 11.5%

Holding current value

$208 Million

Previous $120 Million 48.81%

% of portfolio

0.62%

Previous 0.44%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$592.2 - $792.28 $14 Million - $18.8 Million	23,669 Added 11.5%	229,507 $179 Million
Q4 2023 Feb 06, 2024	SELL	$525.19 - $619.13 $5.87 Million - $6.92 Million	-11,185 Reduced 5.15%	205,838 $120 Million
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $2.97 Million - $4.1 Million	-6,835 Reduced 3.05%	217,023 $117 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $973,654 - $1.3 Million	-2,776 Reduced 1.22%	223,858 $105 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $2.72 Million - $3.2 Million	-8,770 Reduced 3.73%	226,634 $77.8 Million

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $2.34 Million - $2.73 Million	-7,288 Reduced 3.0%	235,404 $86.1 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $2.92 Million - $3.41 Million	9,095 Added 3.89%	242,692 $88.8 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $858,309 - $978,133	2,895 Added 1.25%	233,597 $71.6 Million
Q2 2022 Aug 05, 2022	BUY	$278.73 - $327.27 $9.99 Million - $11.7 Million	35,845 Added 18.4%	230,702 $64.2 Million
Q1 2022 May 09, 2022	SELL	$234.69 - $291.66 $1.45 Million - $1.81 Million	-6,198 Reduced 3.08%	194,857 $55.8 Million
Q4 2021 Feb 07, 2022	SELL	$224.85 - $279.04 $1.03 Million - $1.27 Million	-4,567 Reduced 2.22%	201,055 $55.5 Million
Q3 2021 Oct 28, 2021	SELL	$221.6 - $272.71 $724,410 - $891,488	-3,269 Reduced 1.56%	205,622 $47.5 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $414,542 - $536,207	2,296 Added 1.11%	208,891 $47.9 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $1.84 Million - $2.39 Million	-11,217 Reduced 5.15%	206,595 $38.6 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $1.19 Million - $1.58 Million	-9,126 Reduced 4.02%	217,812 $36.8 Million
Q3 2020 Nov 06, 2020	SELL	$146.22 - $169.13 $283,081 - $327,435	-1,936 Reduced 0.85%	226,938 $33.6 Million
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $848,805 - $1.02 Million	-6,222 Reduced 2.65%	228,874 $37.6 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $997,043 - $1.23 Million	-8,375 Reduced 3.44%	235,096 $32.6 Million
Q4 2019 Feb 07, 2020	SELL	$106.92 - $132.43 $272,539 - $337,564	-2,549 Reduced 1.04%	243,471 $32 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $427,907 - $465,453	-4,007 Reduced 1.6%	246,020 $27.5 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $656,319 - $766,091	-5,924 Reduced 2.31%	250,027 $27.7 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $173,532 - $204,260	-1,559 Reduced 0.61%	255,951 $33.2 Million
Q4 2018 Feb 01, 2019	SELL	$105.9 - $118.64 $928,848 - $1.04 Million	-8,771 Reduced 3.29%	257,510 $29.8 Million
Q3 2018 Nov 09, 2018	SELL	$85.86 - $107.31 $19,919 - $24,895	-232 Reduced 0.09%	266,281 $28.6 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $1.54 Million - $1.77 Million	-20,317 Reduced 7.08%	266,513 $22.7 Million
Q1 2018 May 04, 2018	SELL	$74.21 - $87.6 $981,130 - $1.16 Million	-13,221 Reduced 4.41%	286,830 $22.2 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $471,810 - $506,070	-5,758 Reduced 1.88%	300,051 $25.3 Million
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $358,298 - $397,675	-4,649 Reduced 1.5%	305,809 $26.2 Million
Q2 2017 Aug 11, 2017	BUY	N/A	310,458	310,458 $25.6 Million

Others Institutions Holding LLY

# of Institutions

3,719

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account